Catalyst Event
Sanofi (SNY) · Other
From KEDI U.S. Tech100 90% Participation + Daily Options Premium Index (KUSTC100P)
6/10/2026, 12:00:00 AM
Sanofi announced on June 10, 2026, that it will stop the Phase 3 MOBILIZE study for its drug riliprubart in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) after an independent committee determined it was unlikely to show sufficient efficacy; low impact estimated due to its diversified portfolio.
Korean Translation
사노피는 2026년 6월 10일, 독립적 데이터 모니터링 위원회가 만성 염증성 탈수초성 다발신경병증(CIDP) 환자를 대상으로 한 치료제 리리프루바트의 3상 MOBILIZE 연구가 충분한 효능을 보일 가능성이 낮다고 판단함에 따라 해당 연구를 중단한다고 발표함. 파이프라인 다양성으로 인해 주가 영향은 낮을 것으로 예상됨.
Related Recent Events
Baidu Inc (BIDU) · Earnings Release
Baidu's Q2 2026 earnings release is expected around August 26, 2026. Low importance estimated as pre-release anticipation usually results in minor price fluctuations of 1-5%, expected.
8/26/2026, 12:00:00 AM
Applied Materials Inc (AMAT) · Other
A quarterly dividend of $0.53 per share is expected, with an ex-dividend date of August 20, 2026. Low importance is assigned as standard dividend events typically result in a <5% price impact, expected.
8/20/2026, 12:00:00 AM
Applied Materials Inc (AMAT) · Earnings Release
The Q3 2026 earnings release is scheduled for August 13, 2026. Low importance is assigned as the announcement of a reporting date typically has a <5% price impact, scheduled.
8/13/2026, 12:00:00 AM
Cisco Systems Inc (CSCO) · Earnings Release
Cisco is scheduled to release its Q4 and full fiscal year 2026 earnings on August 12, 2026, scheduled. Market reaction estimated at ≥5% based on historical earnings volatility.
8/12/2026, 12:00:00 AM
Advanced Micro Devices Inc (AMD) · Earnings Release
Q2 2026 earnings release scheduled. The company guided for revenue of approximately $11.2 billion, and analysts forecast EPS around $1.55-$1.60. High importance is estimated due to expected >10% volatility scheduled.
8/4/2026, 12:00:00 AM
Teradyne Inc (TER) · Earnings Release
The next quarterly earnings release on August 4, 2026, which is estimated to have a medium impact (≥5%) as a key financial disclosure event, is scheduled.
8/4/2026, 12:00:00 AM